|
|
||||||||
1 National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.
and2 Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California 92037, U.S.A.
A 4 month old child was immunized with a vaccine containing the Sabin live attenuated vaccine strains of all three serotypes of poliovirus. The antigenic and molecular evolution of the Sabin strain of poliovirus type 3 was then followed throughout the entire period of virus excretion. Novel strains appeared at 8, 42 and 52 days post-vaccination and were the products of both intertypic recombination between type 2 and type 3 poliovirus in regions of the genome coding for non-structural proteins and of point mutations in the region coding for the structural proteins. Excretion of virus continued for 73 days. All strains examined reacted with all monoclonal antibodies specific for the main immunodominant antigenic site of type 3 poliovirus, but variation was observed at other, immunorecessive sites. These findings have possible implications for the evolution of the virus in vaccinees or in epidemics and are consistent with the known antigenic stability of the virus.
Keywords: poliovirus, vaccine, evolution
Received 12 November 1985;
accepted 17 December 1985.
This article has been cited by other articles:
![]() |
J. K. Odoom, Z. Yunus, G. Dunn, P. D. Minor, and J. Martin Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient J. Virol., September 15, 2008; 82(18): 9179 - 9190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zurbriggen, K. Tobler, C. Abril, S. Diedrich, M. Ackermann, M. A. Pallansch, and A. Metzler Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine Appl. Envir. Microbiol., September 15, 2008; 74(18): 5608 - 5614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aaskov, K. Buzacott, E. Field, K. Lowry, A. Berlioz-Arthaud, and E. C. Holmes Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient J. Gen. Virol., December 1, 2007; 88(12): 3334 - 3340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Yakovenko, E. A. Cherkasova, G. V. Rezapkin, O. E. Ivanova, A. P. Ivanov, T. P. Eremeeva, O. Y. Baykova, K. M. Chumakov, and V. I. Agol Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties J. Virol., March 15, 2006; 80(6): 2641 - 2653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Lukashev, V. A. Lashkevich, O. E. Ivanova, G. A. Koroleva, A. E. Hinkkanen, and J. Ilonen Recombination in circulating Human enterovirus B: independent evolution of structural and non-structural genome regions J. Gen. Virol., December 1, 2005; 86(12): 3281 - 3290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, K. Odoom, G. Tuite, G. Dunn, N. Hopewell, G. Cooper, C. Fitzharris, K. Butler, W. W. Hall, and P. D. Minor Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child J. Virol., December 15, 2004; 78(24): 13839 - 13847. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hovi, N. Lindholm, C. Savolainen, M. Stenvik, and C. Burns Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months J. Gen. Virol., February 1, 2004; 85(2): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Mattioli, A. D. Napoli, V. Ferre, S. Billaudel, R. Perez-Bercoff, and J. Cristina Genetic variability of hepatitis A virus J. Gen. Virol., December 1, 2003; 84(12): 3191 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Lukashev, V. A. Lashkevich, O. E. Ivanova, G. A. Koroleva, A. E. Hinkkanen, and J. Ilonen Recombination in Circulating Enteroviruses J. Virol., October 1, 2003; 77(19): 10423 - 10431. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cherkasova, M. Laassri, V. Chizhikov, E. Korotkova, E. Dragunsky, V. I. Agol, and K. Chumakov Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived polioviruses PNAS, August 5, 2003; 100(16): 9398 - 9403. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, G. Crossland, D. J. Wood, and P. D. Minor Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains J. Gen. Virol., July 1, 2003; 84(7): 1781 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dahourou, S. Guillot, O. Le Gall, and R. Crainic Genetic recombination in wild-type poliovirus J. Gen. Virol., December 1, 2002; 83(12): 3103 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, E. Samoilovich, G. Dunn, A. Lackenby, E. Feldman, A. Heath, E. Svirchevskaya, G. Cooper, M. Yermalovich, and P. D. Minor Isolation of an Intertypic Poliovirus Capsid Recombinant from a Child with Vaccine-Associated Paralytic Poliomyelitis J. Virol., October 2, 2002; 76(21): 10921 - 10928. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Egger and K. Bienz Recombination of Poliovirus RNA Proceeds in Mixed Replication Complexes Originating from Distinct Replication Start Sites J. Virol., October 2, 2002; 76(21): 10960 - 10971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Mattioli, J. Cristina, H. Romero, R. Perez-Bercof, D. Casane, R. Colina, L. Garcia, I. Vega, G. Glikman, V. Romanowsky, et al. Molecular Evolution of Hepatitis A Virus: a New Classification Based on the Complete VP1 Protein J. Virol., August 12, 2002; 76(18): 9516 - 9525. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Cherkasova, E. A. Korotkova, M. L. Yakovenko, O. E. Ivanova, T. P. Eremeeva, K. M. Chumakov, and V. I. Agol Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease J. Virol., June 5, 2002; 76(13): 6791 - 6799. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Cuervo, S. Guillot, N. Romanenkova, M. Combiescu, A. Aubert-Combiescu, M. Seghier, V. Caro, R. Crainic, and F. Delpeyroux Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees J. Virol., July 1, 2001; 75(13): 5740 - 5751. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. Gavrilin, E. A. Cherkasova, G. Y. Lipskaya, O. M. Kew, and V. I. Agol Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model J. Virol., August 15, 2000; 74(16): 7381 - 7390. [Abstract] [Full Text] |
||||
![]() |
Y Li, T Peng, Y Yang, C Niu, L C Archard, and H Zhang High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China Heart, June 1, 2000; 83(6): 696 - 701. [Abstract] [Full Text] |
||||
![]() |
J. Martín, G. Dunn, R. Hull, V. Patel, and P. D. Minor Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion J. Virol., April 1, 2000; 74(7): 3001 - 3010. [Abstract] [Full Text] |
||||
![]() |
A. Finn, F. Bell;, P. T HEATH, J. M MACLENNAN, and E R. MOXON Polio vaccine: is it time for a change? • Commentary Arch. Dis. Child., June 1, 1998; 78(6): 571 - 574. [Full Text] |
||||
![]() |
P. Muir, U. Kammerer, K. Korn, M. N. Mulders, T. Poyry, B. Weissbrich, R. Kandolf, G. M. Cleator, and A. M. van Loon Molecular Typing of Enteroviruses: Current Status and Future Requirements Clin. Microbiol. Rev., January 1, 1998; 11(1): 202 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Wright and D. T. Karzon Minimizing the Risks Associated with the Prevention of Poliomyelitis N. Engl. J. Med., February 23, 1995; 332(8): 529 - 530. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |